Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on chiral resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel chiral resolution route for Levosimendan intermediates ensures high optical purity and scalable production for global pharmaceutical supply chains.
Patent CN106432199B reveals ultrasonic resolution for high-purity Ondansetron. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Novel chemical route for D-norvaline from n-pentanoic acid offers cost reduction in API manufacturing and high purity for chiral drug synthesis.
Patent CN106366031B details a novel chiral resolution route for (S)-Oxiracetam offering high purity and scalable manufacturing capabilities for global pharmaceutical supply chains.
Novel chiral synthesis route for octahydro-2H-pyrrolo[3,4-c]pyridine derivatives offering high purity and scalable pharmaceutical intermediate production capabilities.
Novel 4-step route for Elacestrant intermediate. High purity, scalable process for pharmaceutical supply chain cost reduction and efficiency.
Patent CN107129462B details a novel total synthesis of Rupestine G via RCM. We offer scalable manufacturing, cost reduction, and high-purity pharmaceutical intermediates.
This report analyzes patent CN101100462A for levocetirizine production, highlighting cost-effective resolution and scalable alkylation strategies for global pharmaceutical supply chains.
Patent CN101717392A details a novel rotigotine synthesis using chiral phosphoric acid resolution, offering high optical purity and cost reduction in API manufacturing.
Advanced chiral resolution technology for Crizotinib intermediates ensures high purity and cost reduction in API manufacturing for global supply chains.
Novel patent CN112939900B offers high-yield brivaracetam intermediate synthesis with simplified chiral resolution for reliable pharmaceutical intermediate supply chains.
Patent CN104557572A reveals a safer synthesis route for Levalbuterol hydrochloride. Discover cost reduction and supply chain advantages for pharmaceutical intermediates manufacturing.
Novel patent CN118580192B details efficient chiral intermediate synthesis. Offers cost reduction and supply reliability for pharmaceutical manufacturing partners globally.
Patent CN103288801B reveals a novel method for high-purity esomeprazole sodium. Achieves superior chiral purity and eliminates titanium residue for reliable supply.
Novel resolution method for chiral chloroquine phosphate ensures high optical purity and scalable production for pharmaceutical supply chains globally.
Novel vinyl ester amidation route for dihydro-1,3,5-triazine derivatives. High purity, scalable chiral resolution for diabetes treatment intermediates.
Patent CN111205251B details a novel synthesis for (3S,4S)-2,5-dioxytetrahydrofuran-3,4-bis-carbamic acid benzyl ester, offering significant cost reduction and scalable manufacturing for chiral catalysts.
Novel resolution-before-condensation route for Ramosetron HCl. Reduces N-methylindole consumption and boosts yield for scalable API manufacturing.
Patent CN112552184B reveals a scalable 4-step synthesis for cyclopropyl chiral amines, offering significant cost reduction and high purity for pharmaceutical manufacturing.
Patent CN102249937A details a low-cost, non-toxic synthesis for Ivabradine intermediates, offering significant supply chain advantages for API manufacturers.